Surgical treatment of functional mitral regurgitation

International Journal of Cardiology

Volumn 166, Issue 3, 2013, Pages 559-571

  Calafiore, Antonio M ^a   Iacò, Angela L ^a   Gallina, Sabina ^b   Al Amri, Hussein ^a   Penco, Maria ^c   Di Mauro, Michele ^c  

^a PRINCE SULTAN CARDIAC CENTER   (Saudi Arabia)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Functional mitral regurgitation; Mitral valve repair; Mitral valve replacement

Indexed keywords

AORTA VALVE DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PROSTHESIS AND IMPLANT; CHORDAL CUTTING TECHNIQUE; DISEASE SEVERITY; EDGE TO EDGE TECHNIQUE; FUNCTIONAL MITRAL REGURGITATION; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LEAFLET AUGMENTATION; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RESTRICTIVE MITRAL VALVE ANNULOPLASTY; REVIEW; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT INDICATION; ANIMAL; METHODOLOGY; MITRAL VALVE; PATHOLOGY; MITRAL VALVE INSUFFICIENCY; PROCEDURES;

ANIMALS; CARDIAC SURGICAL PROCEDURES; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY;

EID: 84893498208     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.027     Document Type: Review

References (118)

1. Nkomo VT, Gardin LM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-11.
2. Grande-Allen KJ, Borowski AG, Troughton RW, et al. Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements. An extracellular matrix and echocardiographic study. J Am Coll Cardiol 2005; 45: 54-61.
3. Grande-Allen KJ, Barber JE, Klatka KM, et al. Mitral valve stiffening in end-stage heart failure: Evidence of an organic contribution to functional mitral regurgitation. J Thorac Cardiovasc Surg 2005; 130: 783-90.
4. Timek TA, Lai DT, Dagum P, et al. Mitral leaflet remodeling in dilated cardiomy-opathy. Circulation 2006; 114(Suppl. I):I-518-23.
5. Chaput M, Handschumaker MD, Tournoux F, et al. Mitral leaflet adaptation to ventricular remodeling occurrence and adequacy in patients with functional mitral regurgitation. Circulation 2008; 118: 845-52.
6. Lamas GA, Mitchell GF, Flaker GC, et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation 1997; 96: 827-33.
7. Grigioni F, Enriquez-Sarano M, Zehs JZ, Bailey KR, Tajic AJ. Ischemic mitral regurgitation. Long-term outcome and prognostic implications with quantitative doppler assessment. Circulation 2001; 103: 1759-64.
8. Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community. The emerging role of mitral regurgitation. Circulation 2005; 111: 295-301.
9. Grigioni F, Detaint D, Avierinos J-F, Scott C, TajiK J, Enriquez-Sarano M. Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. J Am Coll Cardiol 2005; 45: 260-7.
10. Aronson D, Goldsher N, Zuckermann R, et al. Ischemic mitral regurgitation and risk of heart failure after myocardial infarction. Arch Intern Med 2006; 166: 2362-8.
11. Agricola E, Ielasi A, Opizzi M, et al. Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 2009; 11: 581-7.
12. Bursi F, Barbieri A, Grigioni F, et al. Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study. Eur J Heart Fail 2010; 12: 382-8.
13. Persson A, Hartforf M, Herlitz J, Karlsson T, Omland T, Caidahl K. Long-term prognostic value of mitral regurgitation in acute coronary syndromes. Heart 2010; 96: 1803-8.
14. Rossi A, Dini FL, Agricola E, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 2011; 97: 1675-80.
15. Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11: 307-32.
16. Lancellotti P, Gérard PL, Piérard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005; 26: 1528-32.
17. Beeri R, Yosefy C, Guerrero JL, et al. Mitral regurgitation augments post-myocardial infarction remodeling. Failure of hypertrophic compensation. J Am Coll Cardiol 2008; 51: 476-86.
18. Di Mauro M, Di Giammarco G, Vitolla G, et al. Impact of no-to-moderate mitral regurgitation on late results after isolated coronary artery bypass grafting in patients with ischemic cardiomyopathy. Ann Thorac Surg 2006; 81: 2128-34.
19. Calafiore AM, Mazzei V, Iacò AL, et al. Impact of ischemic mitral regurgitation on long-term outcome of patients with ejection fraction above 0.30 undergoing first isolated myocardial revascularization. Ann Thorac Surg 2008; 86: 458-65.
20. Kim Y-H, Czer LSC, Soukiasian HJ, et al. Ischemic mitral regurgitation: revascular-ization alone versus revascularization and mitral valve repair. Ann Thorac Surg 2005; 79: 1895-901.
21. Mihaljievic T, Lam B-K, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007; 49: 2191-201.
22. Fattouch K, Guccione F, Sampognaro R, et al. Efficacy of adding mitral valve restrictive annuloplasty to CABG in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg 2009; 138: 278-85.
23. Gorman RC Mitral valve surgery for CHF: a failed concept? Cardiosource: American College of Cardiology Website. http://www.cardiosource.com/ expertopinions/hottopics/article.asp?paperID=219.
24. Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 2005; 112: 745-58.
25. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118: e523-661.
26. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-68.
27. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-55.
28. Bolling S, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998; 115: 381-8.
29. Calafiore AM, Iacò AL, Bivona A, et al. Echocardiographically based treatment of chronic ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2011; 141: 1150-6.
30. Czer SLC, Maurer G, Bolger AF, DeRobertis M, Chaux A, Matloff JM. Revascularization alone or combined with suture annuloplasty for ischemic mitral regurgitation. Tex Heart Inst J 1996; 23: 270-8.
31. Gillinov AM, Wierup PN, Blackstone EH, et al. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2001; 122: 1125-41.
32. Grossi EA, Goldberg JD, LaPietra A, et al. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg 2001; 122: 1107-24.
33. Bishay EB, McCarthy PM, Cosgrove DM, et al. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg 2000; 17: 213-21.
34. Calafiore AM, Gallina S, Di Mauro M, et al. Mitral valve procedure in dilated cardiomyopathy: repair or replacement? Ann Thorac Surg 2001; 71: 1146-53.
35. Gummert JF, Rahmel A, Bucerious J, et al. Mitral valve repair in patients with end stage cardiomyopathy: who benefits? Eur J Cardiothorac Surg 2003; 23: 1017-22.
36. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welsh K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005; 45: 381-7.
37. Acker MA, Bolling S, Shemin R, et al. Mitral valve surgery in heart failure: insights from the Acorn clinical trial. J Thorac Cardiovasc Surg 2006; 132: 568-77.
38. Acker MA, Jessup M, Bolling SB, et al. Mitral valve repair in heart failure: five-year follow up from the mitral valve replacement stratum of the Acorn randomized trial. J Thorac Cardiovasc Surg 2011; 142: 569-74.
39. Di Giammarco G, Liberi R, Giancane M, et al. Recurrence of functional mitral regurgitation in patients with dilated cardiomyopathy undergoing mitral valve repair: how to predict it. Interact Cardiovasc Thorac Surg 2007; 6: 340-4.
40. Braun J, van der Veire NR, Klautz RJM, et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg 2008; 85: 430-7.
41. McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgitation after annuloplasty for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2004; 128: 916-24.
42. Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 2007; 49: 2191-201.
43. Zhu F, Otsuji Y, Yotsumoto G, et al. Mechanism of persistent ischemic mitral regurgitation after annuloplasty importance of augmented posterior mitral leaflet tethering. Circulation 2005; 112(Suppl. I):I-396-401.
44. Gelsomino S, Lorusso R, De Cicco G, et al. Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation. Eur Heart J 2008; 29: 231-40.
45. Crabtree TD, Bailey MS, Moon MR, et al. Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann Thorac Surg 2008; 85: 153 7-43.
46. Magne J, Sénéchal M, Mathieu P, et al. Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol 2008; 51: 1692-701.
47. Williams ML, Daneshmand MA, Jollis JG, et al. Mitral gradients and frequency of recurrence of mitral regurgitation after ring annuloplasty for ischemic mitral regurgitation. Ann Thorac Surg 2009; 88: 1197-201.
48. Kubota K, Otsuji Y, Ueno T, et al. Functional mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation: Importance of subvalvular tethering in the mechanism and dynamic deterioration during exertion. J Thorac Cardiovasc Surg 2010; 140: 617-23.
49. Kinkaid EH, Riley RD, Hines MH, Hammon JW, Kon ND. Anterior leaflet augmentation for ischemic mitral regurgitation. Ann Thorac Surg 2004; 78: 564-8.
50. Dobre M, Koul B, Rojer A. Anatomic and physiologic correction of the restricted posterior mitral leaflet motion in chronic ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2000; 120: 409-11.
51. Rendòn F, Aramendi JI, Rodrigo D, Baraldi C, Martinez P. Patch enlargement of the posterior mitral leaflet in ischemic mitral regurgitation. Asian Cardiovasc Thorac Ann 2002; 10: 248-50.
52. de Varennes B, Chaturvedi R, Sidhu S, et al. Initial results of posterior leaflet extension for severe type IIIb ischemic mitral regurgitation. Circulation 2009; 119: 2837-43.
53. De Bonis M, Lapenna E, La Canna G, et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy. Role of the "edge-to-edge" technique. Circulation 2005; 112(Suppl. I):I-402-8.
54. Bhudia SK, McCarthy PM, Smedira NG, Lam B-K, Rajeswaran J, Blackstone EH. Edge to edge (Alfieri) mitral repair: results in diverse clinical settings. Ann Thorac Surg 2004; 77: 1598-606.
55. Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation 2001; 104: 1958-63.
56. Fayad G, Modine T, Le Tourneau T, et al. Chordal cutting technique through aortotomy: a new approach to treat chronic ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2005; 129: 1173-4.
57. Goetz WA, Lim H-S, Lansac M, et al. Anterior mitral basal "stay" chords are essential for left ventricular geometry and function. J Heart Valve Dis 2005; 14: 195-203.
58. Messas E, Yosefy C, Chaput M, et al. Chordal cutting does not adversely affect left ventricle contractile function. Circulation 2006; 114(Suppl. I):I-524-8.
59. Borger MA, Murphy PM, Alam A, et al. Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2007; 133: 1483-92.
60. Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg 2002; 74: 600-1.
61. Langer F, Kunihara T, Hell K, et al. RING+STRING. Successful repair technique for ischemic mitral regurgitation with severe leaflet tethering. Circulation 2009; 120(Suppl. I):S85-91.
62. Hvass U, Tapia M, Baron F, et al. Papillary muscle sling: a new functional approach to mitral repair in patients with ischemic left ventricular dysfunction and functional mitral regurgitation. Ann Thorac Surg 2003; 75: 809-11.
63. Hvass U, Joudinaud T The papillary muscle sling for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2010; 139: 418-23.
64. Fumimoto K, Fukui T, Shimokawa T, Neya K, Suzuki H. Papillary muscle realignment and mitral annuloplasty in patients with severe ischemic mitral regurgitation and dilated heart. Interact Cardiovasc Thorac Surg 2008; 7: 368-72.
65. Rama A, Praschker L, Barreda E, Gandjbakhch I. Papillary muscle approximation for functional ischemic mitral regurgitation. Ann Thorac Surg 2007; 84: 2130-1.
66. Ischikawa S, Ueda K, Kawasaki A, et al. Papillary muscle sandwich plasty for ischemic mitral regurgitation: a new simple technique. J Thorac Cardiovasc Surg 2008; 135: 1384-6.
67. Ramadan R, Al-Attar N, Mohammadi S, et al. Left ventricular infarct placation restores mitral function in chronic ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2005; 129: 440-2.
68. García-Fuster R, Rodríguez I, Estornell J, Martínez-León J. A combined approach for ischemic mitral valve regurgitation: scar plication and the role of magnetic resonance imaging. J Thorac Cardiovasc Surg 2008; 135: 1169-72.
69. Menicanti L, Di Donato M, Frigiola A, et al. Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg 2002; 123: 1041-50.
70. Mandegar MH, Roshanali F, Yousefnia MA, Marzban M. Papillary muscle approximation combined with ventriculoplasty in patients with ischemic cardiomyopathy and functional mitral regurgitation: effects on mitral valve and LV shape. Interact Cardiovasc Thorac Surg 2006; 5: 81-4.
71. Oz MC, Konertz WF, Kleber FX, et al. Global surgical experience with the Acorn cardiac support device. J Thorac Cardiovasc Surg 2003; 126: 983-91.
72. Fukamachi K, Inoue M, Popovic ZB, et al. Off-pump mitral valve repair using the Coapsys device: a pilot study in a pacing-induced mitral regurgitation model. Ann Thorac Surg 2004; 77: 688-92.
73. Starling RC, Jessup M, Oh JK, et al. Sustained benefits of the CorCap cardiac support device on left ventricular remodeling: three year follow-up results from the acorn clinical trial. Ann Thorac Surg 2007; 84: 1236-42.
74. Bredin F, Olsson A, Franco-Cereceda A. No additive effect of passive containment surgery in patients with aortic regurgitation and left ventricular dilation. Ann Thorac Surg 2007; 84: 510-4.
75. Braun J, Ciarka A, Versteegh MIM, et al. Cardiac support device, restrictive mitral valve annuloplasty, and optimized medical treatment: a multimodality approach to nonischemic cardiomyopathy. J Thorac Cardiovasc Surg 2011; 142: e93-100.
76. Speziale G, Nasso G, Piancone F, et al. One-year results after implantation of the CorCap for dilated cardiomyopathy and heart failure. Ann Thorac Surg 2011; 91: 1356-63.
77. Mishra YK, Mittal S, Jaguri P, Trehan N. Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results. Ann Thorac Surg 2006; 81: 42-6.
78. Calafiore AM, Di Mauro M, Gallina S, et al. Mitral valve surgery for chronic ischemic mitral regurgitation. Ann Thorac Surg 2004; 77: 1989-97.
79. Magne J, Pibarot P, Dagenais F, Hachicha Z, Dumesnil JG, Sénéchal M. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation 2007; 115: 782-91.
80. Roshanali F, Mandegar MH, Yousefnia MA, Rayatzadeh H, Alaeddini F. A prospective study of predicting factors in ischemic mitral regurgitation recurrence after ring annuloplasty. Ann Thorac Surg 2007; 84: 745-9.
81. Gelsomino S, Lorusso R, Caciolli S, et al. Insights on left ventricular and valvular mechanisms of recurrent ischemic mitral regurgitation after restrictive annuloplasty and coronary artery bypass grafting. J Thorac Cardiovasc Surg 2008; 136: 507-18.
82. Lee AP-W, Acker M, Kubo SH, et al. Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy importance of distal anterior leaflet tethering. Circulation 2009; 119: 2606-14.
83. Athanasiou T, Chow A, Rao C, et al. Preservation of the mitral valve apparatus: evidence synthesis and critical reappraisal of surgical techniques. Eur J Cardiothorac Surg 2008; 33: 391-401.
84. Al-Radi OO, Austin PC, Tu JW, et al. Mitral repair versus replacement for ischemic mitral regurgitation. Ann Thorac Surg 2005; 79: 1260-7.
85. Milano CA, Daneshmand NA, Rankin JS, et al. Survival prognosis and surgical management of ischemic mitral regurgitation. Ann Thorac Surg 2008; 86: 735-44.
86. Magne J, Girerd N, Sénéchal M, et al. Mitral repair versus replacement for ischemic mitral regurgitation: comparison of short-term and long-term survival. Circulation 2009; 120(Suppl. 1):S104-11.
87. Chan V, Ruel M, Mesana TG. Mitral valve replacement is a viable alternative to mitral valve repair for ischemic mitral regurgitation: a case-matched study. Ann Thorac Surg 2001; 92: 1358-66.
88. Lorusso R, Gelsomino S, Calafiore AM, et al. Mitral valve repair or replacement for ischemic mitral regurgitation? The Italian Study on the Treatment of Ischemic Mitral Regurgitation (ISTMIR). Abstract. San Francisco: AATS; 2012.
89. Yousefnia MA, Dehestani A, Saidi B, et al. Papillary muscle repositioning in valve replacement for left ventricular dysfunction: ischemic mitral regurgitation. Ann Thorac Surg 2010; 90: 497-502.
90. Otsuji Y, Kumanohoso T, Yoshifuku S, et al. Isolated annular dilation does not usually cause important functional mitral regurgitation. Comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic car-diomyopathy. J Am Coll Cardiol 2002; 39: 1651-6.
91. Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation. Reversal with arrhythmia control. J Am Coll Cardiol 2011; 58: 1474-81.
92. Kilic A, Schwartzman DS, Subramanian K, Zenati MA. Severe functional mitral regurgitation arising from isolated annular dilatation. Ann Thorac Surg 2010; 90: 1343-5.
93. Vhora HN, Whistance RN, Magan A, Sadeque SA, Livesey SA. Mitral valve repair for severe mitral regurgitation secondary to lone atrial fibrillation. Eur J Cardiothorac Surg 2012, doi: 10.1093/ejcts/ezs029.
94. Ruel M, Kapila V, Price J, et al. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation 2006; 114(Suppl. I):I-541-6.
95. Pai RG, Varadarajan P. Prognostic implications of mitral regurgitation in patients with severe aortic regurgitation. Circulation 2010; 122(Suppl. 1):S43-7.
96. Absil B, Dagenais F, Mathieu P, et al. Does moderate mitral regurgitation impact early or mid-term clinical outcome in patients undergoing isolated aortic valve replacement for aortic stenosis? Eur J Cardiothorac Surg 2003; 24: 217-22.
97. Wan CKN, Suri RM, Li Z, et al. Management of moderate functional mitral regurgitation at the time of aortic valve replacement: Is concomitant mitral valve repair necessary? J Thorac Cardiovasc Surg 2009; 137: 635-40.
98. Harling L, Saso S, Jarral OA, Kourliouros A, Khider E, Athanasiou T. Aortic valve replacement for aortic stenosis in patients with concomitant mitral regurgitation: should the mitral valve be dealt with? Eur J Cardiothorac Surg 2011; 40: 1087-96.
99. Hwang HJ, Choi E-Y, Kwan j, et al. Dynamic change of mitral apparatus as potential cause of left ventricular outflow tract obstruction in hypertrophic cardiomy-opathy. Eur J Echocardiogr 2011; 12: 19-25.
100. Maron MS, Olivotto I, Harrigan C, et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation 2011; 124: 40-7.
101. Kwon DH, Setser RM, Thamilarasan M, et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart 2008; 94: 1295-301.
102. Harrigan CJ, Appelbaum E, Maron BJ, et al. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Am J Cardiol 2008; 101: 668-73.
103. Schwammenthal E, Nakatani S, He S, et al. Mechanism of mitral regurgitation in hypertrophic cardiomyopathy mismatch of posterior to anterior leaflet length and mobility. Circulation 1998; 98: 856-65.
104. Yu EHC, Omran AS, Wigle ED, Williams WG, Siu SC, Rakowski H. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol 2000; 36: 2219-25.
105. Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordate. J Thorac Cardiovasc Surg 2004; 127: 481-9.
106. Kwon DHJ, Smedira NG, Thamilarasan M, Lytle BW, Lever H, Desai MY. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomy-opathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation. J Thorac Cardiovasc Surg 2010; 140: 317-24.
107. Kofflard MJ, Van Herwerden LA, Waldstein DJ, et al. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1996; 28: 197-202.
108. van der Lee C, Kofflard MJM, van Herwerden LA, Vletter WB, ten Cate FJ. Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy. Circulation 2003; 108: 2088-92.
109. Rankin JS, Binford RS, Johnston TS, et al. A new mitral valve repair strategy for hypertrophic obstructive cardiomyopathy. J Heart Valve Dis 2008; 17: 642-7.
110. Seeburger J, Passage J, Borger MA, Mohr FW. A new concept for correction of systolic anterior motion and mitral valve regurgitation in patients with hypertrophic obstructive cardiomyopathy. J Thorac Cardiovasc Surg 2010; 140: 481-3.
111. Cooley DA, Leachman RD, Hallman GL, Gerami S, Hall RJ. Idiopathic hypertrophic subaortic stenosis. Surgical treatment including mitral valve replacement. Arch Surg 1971; 103: 606-9.
112. Schoendube FA, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ. Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 1995; 92(9 Suppl.): II122-7.
113. Heric B, Lytle BW, Miller DP, Rosenkranz ER, Lever HM, Cosgrove DM. Surgical management of hypertrophic obstructive cardiomyopathy: early and late results. J Thorac Cardiovasc Surg 1995; 110: 195-208.
114. Delahaye F, Jegaden O, De Gevigney G, et al. Postoperative and long-term prognosis of myotomy-myectomy for obstructive hypertrophic cardiomyopathy: influence of associated mitral valve replacement. Eur Heart J 1993; 14: 1229-37.
115. Fighali S, Krajcer Z, Leachman RD. Septal myoectomy and mitral valve replacement for idiopathic hypertrophic subaortic stenosis: short and long term follow up. J Am Coll Cardiol 1984; 3: 1127-34.
116. Walker WS, Reid KG, Cameron EWJ, Walbaum PR, Kitchin AH. Comparison of ventricular septal surgery and mitral valve replacement for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 1989; 48: 528-35.
117. McIntosh CL, Greenberg GJ, Maron BJ, Leon MB, Cannon III RO, Clark RE. Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy. Ann Thorac Surg 1989; 47: 236-46.
118. Gerch BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy, A report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2011; 124:e783-831.